Practical methods for incorporating summary time-to-event data into meta-analysis
- PMID: 17555582
- PMCID: PMC1920534
- DOI: 10.1186/1745-6215-8-16
Practical methods for incorporating summary time-to-event data into meta-analysis
Abstract
Background: In systematic reviews and meta-analyses, time-to-event outcomes are most appropriately analysed using hazard ratios (HRs). In the absence of individual patient data (IPD), methods are available to obtain HRs and/or associated statistics by carefully manipulating published or other summary data. Awareness and adoption of these methods is somewhat limited, perhaps because they are published in the statistical literature using statistical notation.
Methods: This paper aims to 'translate' the methods for estimating a HR and associated statistics from published time-to-event-analyses into less statistical and more practical guidance and provide a corresponding, easy-to-use calculations spreadsheet, to facilitate the computational aspects.
Results: A wider audience should be able to understand published time-to-event data in individual trial reports and use it more appropriately in meta-analysis. When faced with particular circumstances, readers can refer to the relevant sections of the paper. The spreadsheet can be used to assist them in carrying out the calculations.
Conclusion: The methods cannot circumvent the potential biases associated with relying on published data for systematic reviews and meta-analysis. However, this practical guide should improve the quality of the analysis and subsequent interpretation of systematic reviews and meta-analyses that include time-to-event outcomes.
Figures
Comment in
-
Response to: Practical methods for incorporating summary time-to-event data into meta-analysis.Trials. 2013 Nov 19;14(1):391. doi: 10.1186/1745-6215-14-391. Trials. 2013. PMID: 24252445 Free PMC article.
-
Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply.Trials. 2013;14:391. Epub 2013 Nov 19. Trials. 2013. PMID: 24511621 No abstract available.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study.PLoS Med. 2020 Jan 31;17(1):e1003019. doi: 10.1371/journal.pmed.1003019. eCollection 2020 Jan. PLoS Med. 2020. PMID: 32004320 Free PMC article.
-
Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance.Syst Rev. 2025 Apr 10;14(1):84. doi: 10.1186/s13643-025-02752-z. Syst Rev. 2025. PMID: 40211371 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Reducing self-harm in adolescents: the RISA-IPD individual patient data meta-analysis and systematic review.Health Technol Assess. 2024 Jul 10:1-42. doi: 10.3310/GTNT6331. Online ahead of print. Health Technol Assess. 2024. PMID: 39024118
Cited by
-
Role of thoracic radiotherapy in extensive stage small cell lung cancer: a systemic review and meta-analysis.Ann Transl Med. 2021 Feb;9(4):299. doi: 10.21037/atm-20-5765. Ann Transl Med. 2021. PMID: 33708926 Free PMC article.
-
High expression of ANRIL correlated with the poor prognosis in patients with cancer: A meta-analysis.Medicine (Baltimore). 2022 Sep 9;101(36):e30531. doi: 10.1097/MD.0000000000030531. Medicine (Baltimore). 2022. PMID: 36086708 Free PMC article.
-
Comparison of Long-Term Survival Between cT1N0 Stage Esophageal Cancer Patients Receiving Endoscopic Dissection and Esophagectomy: A Meta-Analysis.Front Surg. 2022 May 6;9:917689. doi: 10.3389/fsurg.2022.917689. eCollection 2022. Front Surg. 2022. PMID: 36017523 Free PMC article.
-
Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis.BMC Cancer. 2021 May 25;21(1):600. doi: 10.1186/s12885-021-08316-3. BMC Cancer. 2021. PMID: 34034688 Free PMC article.
-
Clinical significance of circulating tumor DNA in localized non-small cell lung cancer: a systematic review and meta-analysis.Clin Exp Med. 2023 Sep;23(5):1621-1631. doi: 10.1007/s10238-022-00924-y. Epub 2022 Oct 31. Clin Exp Med. 2023. PMID: 36315311
References
-
- Mangioni C, Bolis G, Pecorelli S, Bragman K, Epis A, Favalli G, Gambino A, Landoni F, Presti M, Torri W, Vassena L, Zanaboni F, Marsoni S. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin. Journal of the National Cancer Institute. 1989;81:1461–71. doi: 10.1093/jnci/81.19.1464. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources